The Impact of COVID-19 Pandemic on Clinical Research in China: Challenges and Progress

Frontiers in Medicine

article

Yuan Yang¹  Wen Li¹  Ling Zhang³  Qinge Zhang³  Teris Cheung⁴  Brian J. Hall⁵  Yu-Tao Xiang¹ 

[1] Faculty of Health Sciences, Institute of Translational Medicine, University of Macau;Southern Medical University Nanfang Hospital;The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital & The Advanced Innovation Center for Human Brain Protection, Capital Medical University;School of Nursing, Hong Kong Polytechnic University;New York University (Shanghai)

关键词: COVID-19;    China;    clinical;    research;    progress;   

DOI  :  10.3389/fmed.2020.00523

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

The Novel Coronavirus Disease 2019 (COVID-19 hereafter) was first reported in Wuhan, Hubei province, China at the end of 2019, and then was found in more than 200 countries worldwide. As of April 2020, the COVID-19 outbreak has been well-contained in China. It is beyond doubt that the COVID-19 outbreak has greatly transformed clinical research in China, and this transformation is of interest to the international community. Hence, we believe that a balanced and comprehensive overview describing the impact of COVID-19 on clinical research, the challenges researchers are facing, and an update on the progress of clinical research in China is warranted.

【 授权许可】

CC BY